Clara
Álvarez Villamarín
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublications in collaboration with researchers from Hospital Universitario Marqués de Valdecilla (1)
2018
-
Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476